Search

everythinglearnresearchcommunity

for

Search:↓

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

A girl with Becker's nevus syndrome showed good improvement in breast development using spironolactone.

Hair loss during breast cancer treatment affects each woman differently, influenced by her environment and family.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Most patients tolerated spironolactone for acne and hirsutism despite common side effects like menstrual changes and breast tenderness.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Finasteride is effective for male hair loss, but it may cause fertility issues, mental health problems, and rarely, breast growth. Regular health checks can reduce the risk of prostate cancer. Patient understanding and involvement in treatment is important.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Finasteride can cause rare breast growth side effect, with varying recovery after stopping.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

Finasteride caused breast enlargement in two men, which improved after stopping the medication.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.